SCHEMBL5751193

SCHEMBL5751193

N#Cc1c2[c]cccc2cc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
CLK1 P49759 1/20 0.34
DYRK1A Q13627 1/20 0.34
HSD17B10 Q99714 2/20 0.33
HTR2A P28223 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1B1 Q16678 1/20 0.33
CYP1A2 P05177 4/20 0.33
CYP2C19 P33261 2/20 0.33
PDE9A O76083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28460856 0.84 ALDH1A1 (0.32) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL5746118 0.81 ALDH1A1 (0.43) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL32211 0.80 ALDH1A1 (0.58) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL29391266 0.80 ALDH1A1 (0.58) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL28143357 0.76 ALOX5 (0.39) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL5747987 0.75 ALDH1A1 (0.44) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL5747613 0.75 ALDH1A1 (0.44) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL12679885 0.74 ALDH1A1 (0.50) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL10535409 0.74 CYP2A6 (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL10523695 0.74 PTPN22 (0.41) ALDH1A1KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060293503-A1 Polyaminopyridines and method for producing same SUMITOMO SEIKA CHEMICALS CO., LTD (JP) 2006-12-28 US disclosed
EP-1669390-A1 POLYAMINOPYRIDINES AND METHOD FOR PRODUCING SAME SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2006-06-14 EP disclosed
US-6538161-B2 Naphthalene skeleton substituted with a 1- or 2- position electron donating group and a 6- or 4- position electron attractive group; emitts visible light with a desired color by choosing appropriate combinations TAIHO INDUSTRIES CO., LTD. (JP) 2003-03-25 US disclosed
US-20020156319-A1 Fluorescent compounds HIROSE ENGINEERING CO., LTD. (JP) 2002-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156319-A1 Fluorescent compounds NES, NDC1, DYNC1LI2 ALDH1A1 1215/4885KDM4E 2939/4885CA1 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.